•
Dec 31, 2024

Tscan Therapeutics Q4 2024 Earnings Report

Expected Revenue:$1.51M
-54.8% YoY
Expected EPS:-$0.28
+6.7% YoY
Total Revenue
$665K
Previous year: $7.21M
-90.8%
Gross Profit
-$46K
Previous year: $5.93M
-100.8%
Cash and Equivalents
$290M
Previous year: $192M
+51.1%
Free Cash Flow
-$28.3M
Previous year: -$24.2M
+16.8%
Total Assets
$371M
Previous year: $272M
+36.4%

Tscan Therapeutics

Tscan Therapeutics